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Abstract 
Objective: Episodic memory impairment is at the core of amnestic Mild cognitive impairment (aMCI) 
and Alzheimer’s disease (AD). The origin of memory deficits may result either from an encoding 
deficit or from an accelerated decline of the memory trace. The present study explores these two 
hypotheses. 
Method: We used the DMS-48 (i.e., Delayed-Matching-to Sample 48 items) memory test in a group of 
controls, aMCI patients and AD patients (n= 16 in each group). The DMS-48 offers an incidental 
learning phase followed by three forced-choice recognition tests at three-minute, one-hour and one-
week delays. Moreover, the forced-choice test distinguishes three kinds of couple items: abstract 
(meaningless), paired (two similar exemplars), and unique (two different objects) items.  
Results: As predicted by the accelerated forgetting hypothesis, patients showed a decrease in 
recognition performance over time. Controls also exhibited a similar decline in performance. As 
predicted by the encoding deficit hypothesis, abstract items were the most poorly recognized in AD, at 
both the three minute and one-week delays. In AD, recognition of the paired items also dropped after 
the one-hour delay, followed by unique items after a one-week delay. Patients with aMCI exhibited a 
performance that was similar to controls, except for abstract items, which dropped at the one-week 
delay. 
Conclusions: These results are discussed in light of a third hypothesis, the memory strength 
hypothesis, in order to better account for the progressive decline in memory performance as a function 
of the item type in AD. 
Keywords: episodic memory; Alzheimer’s disease; amnestic mild cognitive impairment; encoding 
deficit; rapid forgetting; memory strength  
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Alzheimer’s Disease and Memory Strength: Gradual Decline of Memory Traces as a Function of 
their Strength 
Episodic memory designates the personal memories of an individual grounded in a specific temporal 
and spatial context (Tulving, 1983, 2002). Memory impairment is at the core of Alzheimer’s disease 
(AD), and of amnestic Mild cognitive impairment (aMCI), considered by many authors to be a 
transitional stage between normal aging and AD (Bäckman, Jones, Berger, Laukka, & Small, 2005; 
Stopford, Snowden, Thompson, & Neary, 2007). In aMCI and AD, encoding, storing and retrieval 
processing are typically impaired, although the degree of impairment is less pronounced in aMCI 
(Greenaway et al., 2006; see also Bennett, Golob, Parker, & Starr, 2006) than in AD (Fleischman & 
Gabrieli, 1999). 
The source of the memory deficits remains nonetheless openly debated (e.g., Ally, Hussey, Ko, 
& Molitor, 2013). Among the different hypotheses proposed (see Carlesimo & Oscar-Berman, 1992), 
the accelerated rate of forgetting hypothesis and the encoding deficit hypothesis appear to be the most 
consensual. The accelerated rate of forgetting hypothesis implies that memory impairment in AD finds 
its origin in the hastened decline of the memory trace. For its part, the encoding deficit hypothesis 
states that AD patients are unable to effectively encode new memories and hence to retrieve them later 
(Larrabee, Youngjohn, Sudilovsky, & Crook, 1993). The accelerated forgetting hypothesis also finds 
evidence in aMCI (Crowell, Luis, Vanderploeg, Schinka, & Mullan, 2002). In one study, aMCI patients 
showed a memory decline as soon as 30 min after the immediate recall tests, but they exhibited a more 
pronounced decline in memory performance than controls at a 6- week than at a 30-min delay (Manes, 
Serrano, Calcagno, Cardozo, & Hodges, 2008). This decline was observed for both verbal and visual 
material in free recall tasks. As in AD, a consolidation impairment was found for aMCI even after 
controlling for encoding (threshold of 90% correct recognition, Walsh et al., 2014). 
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The question of the delay at which memory decline accelerates remains to be determined. Some 
studies reported rapid forgetting after short delays in AD (10-min delay; Hart, Kwentus, Harkins, & 
Taylor, 1988), followed by normalization (comparable slopes between patients and controls) or 
stabilization of the memory performance (Carlesimo, Fadda, Bonci, & Caltagirone, 1993). In contrast, 
other studies reported accelerated forgetting even three months after initial learning (Budson et al., 
2004). In this study, memory performance also appeared to stabilize over time since the rate of decline 
became similar across groups between the three-month and one-year delays (Budson et al., 2007). 
Finally, in support of the rapid forgetting hypothesis, it has been consistently found that delayed 
memory is the most sensitive and specific index (receiver-operating characteristic, ROC analyses) to 
discriminate between AD, aMCI, and healthy aging after a 10-min (e.g., Welsh, Butters, Hughes, 
Mohs, & Heyman, 1992) or 30-min delay (e.g., Estévez-González, Kulisevsky, Boltes, Otermín, & 
García-Sánchez, 2003). Nonetheless, other studies found that the best index to discriminate between 
healthy aging and aMCI or AD (see the review of Carlesimo, Perri, & Caltagirone, 2010) or to detect 
conversion from aMCI to AD (Sarazin et al., 2007) was immediate recall, supporting the encoding 
deficit hypothesis. 
The encoding deficit hypothesis states that aMCI and AD patients are unable to correctly 
encode new verbal and visual material that they are learning (Corkin, 1982; Dick, Kean, & Sands, 
1989), and therefore they are unable to remember it later (see also Becker, Boller, Saxton, & 
McGonigle-Gibson, 1987). The encoding deficit hypothesis is also observed despite controlling for 
initial learning (Christensen, Kopelman, Stanhope, Lorentz, & Owen, 1998). Similar encoding deficits 
have also been reported in AD in both recall and recognition tasks (Martin, Brouwers, Cox, & Fedio, 
1985). The authors argued that AD patients are unable to encode a sufficient number of stimulus 
features or attributes, and therefore their memory traces are not rich enough to be retrieved later on. 
Semantic features are known to provide important benefits to successful encoding in healthy 
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older adults. In contrast, AD patients do not seem to benefit from deeper encoding (i.e. semantic 
processing) and exhibit a flat pattern of recognition across all conditions (Corkin, 1982; see also, 
Grober, Ocepek-Welikson, & Teresi, 2009; Degenszajn, Caramelli, Caixeta, & Nitrini, 2001; Tounsi et 
al., 1999). Furthermore, semantic cueing is not as useful in patients as in healthy older adults. However, 
correctly encoded items appear to remain preserved in memory since AD patients are able to correctly 
recall and recognize these items with the help of semantic cues (Oltra-Cucarella, Pérez-Elvira, & 
Duque, 2014). Conversely, MCI patients benefit from semantic cueing, but only when cognitive 
support is provided (cued recall), although they show less semantic clustering than healthy adults 
(Ribeiro, Guerreiro, & De Mendonça, 2007). 
Taken together, these data do not allow us to clearly conclude in favor of either the encoding or 
the accelerated decline hypotheses in aMCI and AD. One could argue that a combination of encoding 
and consolidation deficits may account for the memory impairment observed in these conditions. In 
support of this view, several studies have reported a significant impairment of both encoding and 
consolidation in aMCI and AD (e.g., Delis et al., 1991; Reed, Paller, & Mungas, 1998). For instance, 
Moulin et al. (Moulin, James, Freeman, & Jones, 2004) compared the performance of aMCI and AD 
patients with that of controls on three different memory tasks. They found that patients exhibited both 
encoding and consolidation deficits, and these deficits were not correlated. The authors thus concluded 
that two different mechanisms were responsible for the memory deficits. According to another view 
(Ally et al., 2013), aMCI and AD are on a continuum. Patients with aMCI are able to correctly encode 
new information due to the mild nature of their memory impairment, but they suffer from a rapid 
decline of the memory trace. In contrast, with the progression of cognitive decline, AD patients suffer 
from both accelerated decline and impaired encoding. 
According to the encoding deficit hypothesis, it can be hypothesized that once encoding has 
been controlled for, a similar rate of forgetting should be observed between groups, whereas the 
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accelerated forgetting hypothesis predicts the opposite. However despite the different methods used to 
equate learning, some studies still found a more rapid decline of the memory trace despite attempts to 
control for encoding performance (Larrabee et al., 1993; Walsh et al., 2014), while others did not 
(Christensen et al., 1998; Kopelman, 1985). 
The lack of consistency in these findings may be due to methodological discrepancies across 
studies. Nevertheless, effects predicted by each hypothesis were found regardless of the population 
(aMCI vs. AD), the task (recognition vs. free recall), and the material (verbal vs. visual). Surprisingly, 
almost all the studies reported above appeared to use an explicit learning phase1. Therefore, it is 
difficult to exclude the possible contribution of executive functioning in memory performance. It is 
well known that executive functions are involved in episodic encoding and recall in healthy young 
adults, healthy older adults (Troyer, Graves, & Cullum, 1994), and individuals with aMCI or AD (e.g., 
Bisiacchi, Borella, Bergamaschi, Carretti, & Mondini, 2008). Furthermore, to our knowledge, no study 
has manipulated inherent properties of items to be learned as based on the dual coding theory (Paivio, 
1990). This theory posits that pictures of common objects benefit from dual coding involving their 
visual features and verbal labels, whereas abstract concepts and abstract pictures are considered to be 
encoded only on their visual features. Abstract items should thus be considered as weaker, and they 
should lead to a poorer encoding than common objects. 
The present study aims to confront the encoding and accelerated forgetting hypotheses in aMCI 
and AD by manipulating (a) the delay in an incidental memory task; and (b) the nature of the items. 
Memory performance of healthy elderly (HE), aMCI, and AD patients was assessed using the DMS-48 
(Delayed-Matching-to Sample 48 items, Barbeau et al., 2004) in order to specifically investigate the 
respective roles of encoding versus forgetting memory processes. We chose the DMS-48 because it is 
 
1 It was not always specified whether or not the learning phase was explicit or incidental. 
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commonly used in clinical practice, it offers an incidental learning phase followed by three forced-
choice visual recognition tests including a one-week delay, and it also distinguishes three different 
types of items in the recognition phases. Unique items include a picture of a real object (the target, 
e.g., a tree) presented along with an unrelated distractor (e.g., a book); Paired items include a real 
object (the target) presented along with another exemplar of the same category (e.g., two different 
models of cars). Finally, abstract items include both an abstract target and an abstract distractor 
(meaningless visual shapes, difficult to verbalize). 
According to the rapid forgetting hypothesis, the most important decline in performance in the 
aMCI and AD groups should be found between the three-minute and one-hour delays when compared 
to the HE group. However, a decline in performance should also be noted, but to a lesser extent, 
between the one-hour and the one-week delays. The decline rates should be the same regardless of the 
type of items (unique, paired, or abstract). According to the encoding deficit hypothesis, aMCI and AD 
patients should present with the greatest deficits after the three-minute delay (irrespective of item type), 
whereas a relatively similar decline across aMCI, AD, and HE groups should be observed at the 
subsequent one-hour and one-week delays. Moreover, dual-coded items (visual + semantic: unique and 
paired items) should be better recognized than single-coded items (abstract items), because dual-coded 
items are assumed to have been encoded more profoundly, according to Paivio’s (1990) dual-coding 
theory. 
Methods 
The present study was approved by the Ethics committee of the Research Center of Institut 
universitaire de gériatrie de Montréal and complies with the recognized standards on human 
experimentation (Helsinki Declaration of 1975, 2000). All participants signed an informed consent 
form before the start of the experimental session. A one-week delay separated the two sessions. They 
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received a monetary compensation ($40) for their participation. 
 
 
Participants 
A total of 53 participants were recruited. Five participants with AD were excluded due to the 
fact that they did not complete the one-week delay test of the DMS-482. Thus, 48 participants were 
included in the present study (see Table 1). These participants were divided into three groups: 16 
healthy elderly (HE), 16 patients with an amnestic Mild Cognitive Impairment (aMCI), and 16 patients 
with Alzheimer’s disease (AD). Diagnosis of aMCI and AD patients was confirmed during a consensus 
meeting. All aMCI patients received a diagnosis of probable aMCI according to the criteria proposed 
by Petersen (Albert et al., 2011; Petersen, 2004). All of them reported a subjective memory complaint 
and exhibited a mild episodic memory impairment –that is, more than 1.5 standard deviations below 
the norm on standardized memory tests. None of them reported a significant impact of their memory 
impairment on their activities of daily living. All AD patients received a diagnosis of probable 
Alzheimer’s disease according to the Diagnostic and Statistical Manual of Mental Disorders–Fourth 
Edition (DSM –IV; American Psychiatric Association, 1994) and the National Institute of Neurological 
and Communicative Disorders and Stroke–Alzheimer’s Disease and Related Disorders Association 
(NINCDS-ADRDA) criteria (McKhann et al., 1984). They were in the early to moderate stages of the 
 
2  The five AD patients excluded did not differ from those who completed all of the memory subtests, in 
terms of age, education, global cognitive functioning (MMSE and MOCA) and scores on the first two sets of 
the DMS-48. 
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disease as defined by a Mini-Mental State Examination (MMSE) score between 20 and 28. All aMCI 
and AD patients were recruited at the Notre-Dame Hospital and the Institut universitaire de gériatrie de 
Montréal. Participants in the HE group were recruited in the Institut universitaire de gériatrie de 
Montréal and by public announcements in the community. Participants in the HE group were matched 
for education and age with aMCI and AD patients (see Table 1). 
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 Table 1. Means (and standard deviations) of demographic and global cognitive functioning data for the healthy elderly 
(HE), amnestic MCI (aMCI) and patient with Alzheimer’s disease (AD). 
 
 
HE 
(n=16)  
aMCI 
(n=16)  
AD 
(n=16)  
p  Comparison  
Demographic  
  Age  74.94 (7.5)  78.19 (6.1)  77.44 (5.9)  0.35  HE = aMCI = AD  
  Sex (M/F)  4/12  5/11  5/11  NA  NA  
  Education (years)  14.88 (3.9)  14.94 (4.1)  12.22 (4.1)  0.11  HE = aMCI = AD  
Global  
  MMSE  
  MoCA  
28.94 (1.1)  28.31 (1.5)  24.81 (2)  <0.001***  HE = aMCI > AD  
28.06 (1.5)  25.62 (2.1)  20.31 (3.4)  <0.001***  HE > aMCI > AD  
 
Note. Means; standard deviations in parentheses. HE = healthy elderly; aMCI = amnestic MCI; AD = Alzheimer’s disease; 
M = male; F = female; MMSE = Mini-Mental State Examination; MoCA = Montréal Cognitive Assessment; NA = analysis 
not computed. p = p values computed for each analysis of variance (ANOVA) with the group (HE, aMCI, AD) as a between 
-subjects variable. *p < .05 . **p < .01. ***p < .001. 
Health information was gathered from all participants during an extensive medical history and 
neuropsychology interview. Participants with a medical history and/or taking medications for 
conditions with known sensory or neurological effects were excluded. Participants who reported a 
diagnosis of depression or anxiety were included only if they were stable on their medication and if 
they were nonsymptomatic at the time of the study. All participants in the study were native French 
speakers and demonstrated adequate speech, visual, and hearing performances. Furthermore, all 
participants underwent a comprehensive neuropsychological assessment which was used to assess for 
the inclusion and exclusion criteria.  
Materials and procedure 
We chose the DMS-48 because this test is based on clear hypotheses concerning which aspect 
of memory should be impaired first in AD (Barbeau, Tramoni, et al., 2004; reviewed in Didic et al., 
2013). The DMS-48 is a two-alternative forced-choice visual recognition task based on the classic 
delayed matching-to-sample task used in animals. The DMS-48 offers the following advantages: (a) 
There is an incidental learning phase –that is participants are unaware they are performing a memory 
test. Participants see a set of 48 colored drawings, which can represent objects, animals or abstract 
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pictures. Yet, encoding is ensured by asking participants whether or not the picture is composed of 
three or more colors thus requiring a certain detail of perceptual analysis. Consequently, due to the 
incidental learning procedure, memory performance on this test should be not affected by executive 
functions or strategic encoding deficits; (b) after an interfering 2-min fluency task, participants 
complete an immediate (Set 1, 3 minutes later), followed by a delayed (Set 2, 60 min later) and a long 
delayed (Set 3, 1 week later) forced-choice recognition task in which two drawings are presented at a 
time. Thus participants do not rely on effortful retrieval processes during the recognition phases; (c) 
this test is one of the very few developed tests that allows us to assess memory after a relatively long 
delay (i.e., one week-delay), a notable advantage over other tests. (d) The DMS-48 also enables to 
examine memory performance for three different types of items: unique (tree vs. book), paired (two 
different models of cars), and abstract items (meaningless visual shapes, difficult to verbalize). Unique 
items do not share semantic and perceptual features (color, shape, etc.) as opposed to paired items. 
Some of the abstract distractors also share visual features with their associated target (see examples in 
Appendix).  
The following measures were recorded for each participant at each delay: Total – number of 
correct items recognized across all conditions; Unique – number of correct unique items recognized; 
Paired – number of correct paired items recognized and Abstract – number of correct abstract items 
recognized. 
Statistical Analyses 
Analyses of variance (ANOVAs) were conducted on the Total scores (sum of correct 
recognition across conditions) with the Group (HE vs. aMCI vs. AD) as between-subjects variable and 
the Time (immediate vs. 1 hour vs. 1 week) as within-subjects variable. An item type ANOVA was 
also conducted on the scores of each condition with the Group (HE vs. aMCI vs. AD) as between-
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subjects variable and the Time (immediate vs. 1 hour vs. 1 week) and the Item type (unique vs. paired 
vs. abstract) as within-subjects variables. Mauchly’s test for sphericity was conducted for each 
ANOVA to assess the homogeneity of variance, and the analyses did not reveal any significant effect. 
Therefore, the ANOVAs were not corrected. Post hoc analyses were computed using unilateral 
Student’s t-test corrected for multiple comparisons using the Holmes procedure. A p value of <.05 was 
used as significant threshold for all the analyses. One AD patient did not complete the last set of the 
DMS-48 (set 3). Thus, resulting missing values were replaced by the different means of the group of 
AD patients in the different conditions (total, abstract, paired, unique). 
Results 
Total Scores 
The ANOVA performed on the Total scores of the DMS-48 (see Figure 1) revealed a main 
effect of the Group, F(2, 45) = 37.79, p < .05, η2g = .56. HE (M = 46, SD = 2) performed better than 
aMCI patients (M = 45, SD = 2.9) who performed better than AD patients (M = 36, SD = 6.2; all 
p < .05). The Time factor was also significant, F(2, 90) = 5.24, p < .05, η2g = .03. A significant 
difference was observed between immediate recognition and one-week delay (p < .05), but there was 
no difference between immediate recognition and one-hour delay (p = .1), nor was there a difference 
between the one-hour and one-week delay (p = .1). Finally, the Group by Time interaction was not 
significant, F(4, 90) <  1. 
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Item-type 
Beyond the effect of Group and Time factors (see the Total Scores subsection), the item-type 
analysis revealed a significant effect of the Item-type factor, F(2, 90) = 22.46, p < .05, η2g = .08 with 
the Unique items better recognized than the Paired and Abstract items (p < .05) which were marginally 
different one from each other (p = .06). 
The Group by Item-Type interaction (F(4,  90) < 1) as well as the double interaction Group by 
Time by Item-Type (F(4, 180) = 3.16, p < .05, η2g = .02) were significant. 
The double interaction was decomposed by running separate ANOVAs on each group (see 
 
Figure 1. Total correct recognition hits for healthy control (HE), amnestic MCI patients (aMCI), 
and patients with Alzheimer’s disease (AD) at different delays. Grey ribbons represent standard 
errors corrected for within-subjects design. 
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Figure 2). The ANOVA performed in the HE group showed only a significant effect of the Item-Type 
factor, F(2, 30) = 3.47, p < .05, η2g = .06, whereas the Time factor (F(2, 30) = 1.26, p = .30, η2g = .01) 
and the Time by Item-type interaction (F(4, 60) = 1.32, p = .27, η2g = .02) were not significant. Unique 
items were better recognized than paired and abstract items (p < .05), but no difference was observed 
between paired and abstract items (p = .23). 
The ANOVA performed with the aMCI group revealed the same pattern of results as that in the 
HE group. The only significant effect was observed for the Item-Type factor, F(2, 30) = 6.56, p < .05, 
η2g = .08, whereas a trend was observed for the Time factor (F(2,30) = 2.74, p = .08, η2g = .03) and no 
effect for the Time by Item-type interaction (F(4,60) = 1.06, p = .38, η2g = .02). Unique items were 
better recognized than paired and abstract items (p < .05), but no difference was observed between 
paired and abstract items (p = .20). 
Finally, the ANOVA performed in the AD group revealed a significant effect of the Item-type 
factor, F(2,30) = 13.33, p < .05, η2g = .11 and of the Time by Item-Type interaction, F(4,60) = 3.70, 
p < .05, η2g = .05. A trend was observed for the Time factor, F(2,30) = 2.47, p = .10, η2g = .02. In the 
immediate recognition test, the unique and paired items (p = .47) were better recognized than abstract 
items (p < .05), whereas Unique items were better recognized than paired and abstract items in both the 
one-hour and the one-week later tests. In these recognition test times, paired and abstract items were 
not differently recognized (p = .28, p = .37 respectively). 
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Figure 2 suggests a possible decline in performance in aMCI for abstract items at the one-week 
delay. As this observation may be consistent with the statistical analyses reported in the AD group, we 
conducted an exploratory analysis on the item type in aMCI group at the one-week delay, despite the 
fact that the Recognition Time by Item Type factor was not significant in this group. Pairwise t tests 
indicated that fewer abstract items were recognized than unique items (p < .05) supporting the 
descriptive observation. Recognition of abstract and paired items did not differ significantly (p = .13), 
but marginally fewer paired items than unique items were recognized (p = .08). 
 
Figure 2. Number of hits per item type for healthy control (HE), amnestic MCI patients (aMCI), and patients with 
Alzheimer’s disease (AD) at the three delays (immediate, 1 hour, 1 week). Grey ribbons represent standard errors 
corrected for within-subjects design. 
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Discussion 
The present study aimed to test the accelerated forgetting and the encoding deficit hypotheses of 
memory deficits in aMCI and AD. We used the DMS-48 test in order to compare recognition 
performance of HE, aMCI, and AD patients at immediate recognition, one-hour, and one-week delays. 
Contrary to most of the clinical tests used to assess episodic memory, the DMS-48 provides an 
incidental learning phase followed by three recognition phases. Therefore, by limiting the contribution 
of executive processes, it can be considered to assess “purer” memory processes. Another advantage of 
this test is that it allows us to compare recognition of three different item types: unique, paired and 
abstract. We discuss the results in light of both hypotheses. Since the data are in partial agreement with 
both of these two hypotheses, we propose a third possible interpretation based on the memory strength 
theory inspired from studies in normal cognition.  
On the one hand, the rapid decay hypothesis assumes that recognition of all three item types 
rapidly declines over time in aMCI and AD compared to controls. It could also be assumed that the 
decrement would be more important between immediate and one-hour delays than between one-hour 
and one-week delays. Nonetheless, we did not observe a significant decline in performance between 
immediate recognition and one-hour delays. Recognition rates, however, were significantly poorer after 
one-week delay than at immediate recognition in all groups. This more pronounced drop in 
performance after a one-week delay has been recently reported by Walsh et al. (2014) in people with 
aMCI. A more rapid decline has been reported in AD (see, for instance, Carlesimo et al., 1993; Hart et 
al., 1988). Contrary to what would be predicted by the rapid decay hypothesis, the decline over time in 
the current study was, however, similar in patients and HE. The difference in findings between the 
present study and other studies reported in the literature may result from the intrinsic properties of the 
DMS-48. Finally, when looking more specifically at the item types, not all types declined over time, as  
would have been predicted by the rapid decay hypothesis. Abstract items were the most poorly 
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recognized items, but their level of recognition remained almost identical across all delays in the three 
groups. This difficulty cannot be explained by a deficit in semantic elaboration in aMCI or AD since 
(a) they are known to benefit from the depth of encoding for pictures (picture superiority effect, Ally, 
Gold, & Budson, 2009), and (b) HE also showed a similar effect (but see Joubert et al., 2010). 
On the other hand, the encoding hypothesis would predict deficits in aMCI and AD in 
immediate recognition, while a decline rate similar to controls would be predicted at subsequent delays. 
As reported above, performance declined similarly in all groups between immediate recognition and 
the one-week delay, but not between immediate and one-hour delays. Yet, as predicted by the encoding 
hypothesis, abstract items were more poorly recognized than unique and paired items in AD. This 
particular difficulty can be interpreted as resulting from the “dual coding” (Paivio, 1990) of unique and 
paired items (visual features + semantic label) relative to the single coding of abstract items (visual 
features only). Abstract items may thus not gain from deeper encoding and/or semantic elaboration 
(Craik & Tulving, 1975), as opposed to paired and unique items. They may therefore be more difficult 
to recognize. Nonetheless, the difference in immediate recognition performance between unique and 
paired items in AD would not be predicted by the encoding hypothesis, since unique and paired items 
should be expected to benefit equally from dual coding. 
The fact that unique items were better recognized than paired items may thus depend on task 
difficulty. It is indeed harder to distinguish among previously seen items between two very similar than 
two very distinctive items (e.g., Koutstaal & Schacter, 1997). It has been shown that AD patients are 
able to benefit from conceptual and visual distinctive features in memory (Deason, Hussey, Flannery, 
& Ally, 2015). Therefore, one can imagine that the worse performance of aMCI and AD patients than 
of HE comes from a degradation in the quality of memory traces. According to the fuzzy-trace theory 
(Brainerd & Reyna, 2002), the verbatim process allows one to retrieve a memory as a whole with all its 
associated details, whereas the gist process refers to more generic and less detailed features. Previous 
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data have shown that AD patients, and to some extend aMCI patients (Hudon et al., 2006), exhibit a 
verbatim impairment and thus rely to a greater extent upon gist memory (e.g., Budson, Todman, & 
Schacter, 2006). Therefore, these patients exhibit worst performance in recall and correct recognition of 
items, especially when these items are presented with similar distractors. Memory performance of 
aMCI and AD patients in the present study could thus be explained by an encoding deficit combined 
with a greater reliance on gist memory. 
Nonetheless, an interpretation based on these two hypotheses seems insufficient to account for 
the main finding of the present study regarding the pattern of recognition impairment in AD over time 
as function of item type. In AD, abstract items were more poorly recognized from the beginning 
(immediate recognition) and the degree of recognition of abstract items remained the same at 
subsequent delays. Paired and unique items were more poorly recognized in AD than in aMCI and HE 
groups during immediate recognition, but were significantly better processed than abstract items in the 
AD group. At the one-hour delay, recognition of paired items declined at the same rate of recognition 
of abstract items in AD, whereas recognition rates of unique items remained the same both at 
immediate and at one-hour delays. Finally, recognition of unique items declined after one week in AD 
patients, although these items remained better recognized at this delay than abstract and paired items. 
The progressive decline in recognition memory over time as a function of item type evokes a 
loss of the strength or distinctiveness of the memory traces. Weaker traces should decline more rapidly 
over time than stronger traces and should also be less distinctive. Abstract items are particularly 
vulnerable since the traces created during their encoding are shallower –that is, weaker– than unique 
and paired items due the single encoding of the item (only visual compared to both visual and semantic 
features). This strength-based hypothesis (see Rohrer, 1996 for data in normal cognition) may also 
account for the progressive decline of paired and then unique items in recognition memory 
performance in AD. Compared to HE, the weaker memory traces in AD make them (a) decline more 
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rapidly over time, which explains the difference between the groups, and (b) less distinctive, which 
explains why paired items decline before unique items. This idea of memory trace weakening was put 
forward in previous studies to account for amnesia. For instance, memory performance of amnesic 
patients may be reproduced in healthy young and/or elderly adults by increasing the delay of testing 
(Van der Linden & Bruyer, 1991) or by degrading the perceptual information available (HE, aMCI and 
AD patients, Cronin-Golomb, Gilmore, Neargarder, Morrison, & Laudate, 2007). These effects were 
interpreted by the authors based on previous findings that amnesic patients have weaker memory traces 
than controls (see also Berry, Kessels, Wester, & Shanks, 2014). Alternatively, weaker memory traces 
may decline at a similar rate than stronger traces. The difference in performance may thus result from 
the activation/strength needed to pass a certain threshold below which a memory trace may not be 
accurately retrieved (see activation models of memory, such as MINERVA, Hintzman, 1984).  
One implication of the strength-based hypothesis is that it gives a more central role of the 
sensorimotor components in the distinctiveness, and therefore in the strength, of the memory traces as 
demonstrated in young and healthy elderly adults (e.g., Brunel, Goldstone, Vallet, Riou, & Versace, 
2013; Vallet, Simard, Versace, & Mazza, 2013). This role, combined with the disconnection syndrome 
reported in AD (Delbeuck, van der Linden, & Collette, 2003), might also account for some of the 
memory disorders in AD (see Vallet, Hudon, Simard, & Versace, 2013). Therefore, one may envision 
improving memory stimulation programs by focusing on sensorimotor components and their 
integration into the memory trace (e.g., Maseda, Sánchez, Marante, González-Abraldes, Buján, & 
Millán-Calenti, 2014). 
The memory strength hypothesis is partially supported in aMCI as indicated by the exploratory 
analysis in the present study. Abstract items started to significantly decline in the one-week delay 
whereas unique items remained the best recognized item type. In other words, this pattern suggests that 
abstract items may be the most vulnerable to decline in aMCI, but this effect may take more than a one-
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week delay to become clinically relevant and significant (at least in our group of aMCI patients). This 
finding may appear surprising since one might expect the performance of aMCI patients to stand 
midway between that of HE and AD patients. We found that AD patients exhibited the worst 
performance followed by the aMCI patients and then the HE as previously reported with DMS-48 test 
(Barbeau, Didic, et al., 2004; Didic et al., 2013). Nonetheless, in the current study the performance of 
the aMCI group was much similar to that of the HE group. This differs from previous studies and may 
be due to the fact that our aMCI group appeared to be globally less cognitively impaired than in other 
studies, such as indicated by the mean MMSE scores, and this despite the fact that our group was older 
(MMSE: 28.3 vs.27.1 vs. 26.6; Age: 78.1 vs. 71.8 vs 71.0 in the present study, in Didic et al., 2013 and 
Barbeau et al., 2004b respectively). Thus, more cognitively impaired aMCI patients may present lower 
scores for the abstract items. Future studies could address this issue by taking into account the item-
type factor into the analyses of performance of aMCI patients in the DMS-48 test. Further studies 
should also attempt to determine whether global processing of objects such as the stimuli used in the 
current study may be affected in AD and whether this may have an impact on performance. Finally, the 
modest sample size of the groups may reduce the statistical power of the study and results should 
therefore be interpreted accordingly. 
One point that deserves mention is that the items in the DMS-48 test are context-free, as 
opposed to context-rich items in other memory tests (e.g., Family pictures subtests from the Wechsler 
Memory Scale; Wechsler, 1997). In fact, context-free recognition is presumed to rely on the perirhinal 
cortex, and this structure is indeed believed to be the first to be affected in AD (Barbeau, Sonetheiner, 
et al., 2004; Barbeau, Tramoni, et al., 2004; Braak & Braak, 1991). Therefore, tests that rely upon 
context-free memory may detect the first detectable sign of memory impairment in AD (Didic et al. 
2011). Once again, it is worth mentioning that the DMS-48 is unique in that it allows us to assess 
episodic memory using an incidental learning phase combined with a simple forced-choice recognition 
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task. Most of the episodic tests commonly used in clinical practice rely on explicit learning and on a 
combination of free-recall and/or recognition tasks. 
The present study is among the few testing memory performance at a one-week delay, and it is 
the first to follow an item-type approach to analyze the data of the DMS-48. This approach allowed us 
to find a very specific pattern of recognition impairment in AD, with worst performance for abstract 
items at immediate delays followed by paired items at a one-hour delay and unique items at a one-week 
delay. This pattern of memory impairment in AD is neither compatible with the rapid decay hypothesis 
nor compatible with the encoding deficit hypothesis nor even with a combination of these two 
hypotheses. We proposed an alternative interpretation based on the strength of the memory trace taking 
into account both encoding and retrieval processes over time. However, our results are limited to 
recognition memory. Future studies are thus needed to test whether these results can be extended to 
free-recall paradigms. To summarize, the strengths of the present study are that: (a) the cognitive load 
is reduced by proposing an incidental learning phase and forced-choice recognition tasks; (b) a more 
qualitative approach is followed by considering an item-type analysis; (c) we use a clinical memory test 
designed to assess memory performance up to a one-week delay; (d) we contrast performance of 
patients with mild-cognitive impairment and patients with AD with healthy elderly adults. However, 
the present study is limited by (a) the particularities of the DMS-48 compared to more commonly used 
memory tests (incidental, context-free, recognition only); (b) the MCI patients being only mildly 
impaired; (c) the limited sample size. Considering the particularity of the DMS-48, our findings need to 
be replicated using more commonly used tests of episodic memory to further explore and understand 
the strength-based hypothesis. 
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Appendix 
Examples of stimuli used in the DMS-48 as a function of the item type (unique, paired, abstract) and of 
the recognition delay (3 min., 1 hour, 1 week). Note that items are in color in the original format. 
 
 
 
